CRLBF · Cresco Labs Inc. · Metrics
$0.57
-0.02 (-4.11%)
At close · Nov 5
Return incl. dividend (before tax)
Earnings today
Play latest call
Q3 2026 earnings call transcript
Market Cap
$210.67M
Shares
370.24M
Volume · Nov 5
510K
Avg daily vol (3M)
524.97K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
CRLBF metrics
54 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$0.57
Market cap
$210.67M
Price action
20 metricsPrice change (1W)
-3.2%
Price change (30D)
-7.3%
Price change (3M)
-7.6%
Price change (6M)
-46.1%
Price change (YTD)
-51.8%
Price change (1Y)
-44.5%
Trailing year
Price change (5Y)
-92.3%
52-week high
$1.92
52-week low
$0.57
Change from 52-week high
-69.0%
Change from 52-week low
+3.6%
Annualized volatility
134.1%
Annualized volatility (3M)
73.1%
Beta
1.2
RSI (14D)
43.1
Price vs SMA 50
-13.4%
Price vs SMA 200
-30.3%
Avg volume (3M)
520,805
Relative volume
1.3
Average dollar volume
$361,209
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
370.24M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.6
reciprocal yield 155.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
2026-11-06
Last earnings
2026-08-06
Profitability
9 metricsGross margin
49.5%
Operating margin
-4.3%
Trailing 12 months
Net margin
-20.6%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-9.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.8%
Year over year · more shares
Revenue CAGR (3Y)
-8.0%
Revenue CAGR (5Y)
+6.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-39.8%
Return on assets
-11.3%
Debt / equity
1.0
Current ratio
2.6
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$335.12M
Latest balance sheet
Cash & equivalents
$57.90M
Total assets
$1.20B
Total debt
$472.68M
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
7
13F filer change QoQ
-3
Institutional ownership
0.0%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-50.0%
Holder tenure
25.3
Price vs estimated holder cost
-88.3%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.4%
Latest settlement · 1.3 days to cover
Days to cover
1.3d
Short-squeeze score
51 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—